ResearchBarriers to Diagnosis and Treatment of Clostridioides difficile Infection: A Narrative Review
ResearchFood and Drug Administration-Approved Fecal Microbiota-Based Therapies for Recurrent Clostridioides difficile Infection
ResearchBurden of Emergency Department Visits and Their Outcomes Among Patients With Rheumatoid Arthritis: Insights From the Nationwide Emergency Department Sample
ResearchBody mass index changes after fecal microbiota transplantation for recurrent Clostridioides difficile infection
ResearchReal-world use of bezlotoxumab to prevent recurrent Clostridioides difficile infections: a single-center experience and meta-analysis
ResearchFecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection